Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples